10/22/21 7:30 AMNasdaq : NTRB, NTRBWofferingNutriband Inc. Receives Additional $2,062,500 from Exercise of Warrants, Increasing Total Capital from Public Offering and Nasdaq Listing to Approx. $8.7MNutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of pharmaceutical products, contract research and development services, and the manufacture of transdermal products, is pleased to announce the receipt of $2,062,500 inRHEA-AIneutral
10/12/21 7:30 AMNasdaq : NTRB, NTRBWcovid-19Nutriband Inc. Signs Exclusive Manufacturing Agreement for Diocheck(TM) Visual COVID-19 Antibody Indicator PatchNutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of pharmaceutical products, contract research and development services and the manufacture of transdermal products, today announced that it has signed an exclusiveRHEA-AIvery positive
10/06/21 8:30 AMNasdaq : NTRBofferingWallachBeth Capital Announces Completion of a $6.6 Million Underwritten Public Offering for Nutriband Inc. (NASDAQ: NTRB) and Up-listing to the NASDAQ Capital MarketWallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced the completion of an underwritten public offering of 1,056,000 units for Nutriband Inc. (NASDAQ: NTRB) at a public offering price of $6.25RHEA-AIneutral
10/05/21 3:35 PMNasdaq : NTRB, NTRBWofferingWestPark Capital Announces Completion of a $6.6 Million Public Offering for Nutriband Inc. (NASDAQ: NTRB) and Up-listing to the NASDAQ Capital MarketNutriband Inc., a company engaged in the development of pharmaceutical products, contract research and development services and the manufacture of transdermal products focused on preventing opioid abuse, announced that its common stock and warrants began trading on the Nasdaq Capital Market effective October 1, 2021. Nutriband also announced the...RHEA-AIneutral
10/04/21 7:30 AMNasdaq : NTRB, NTRBWNutriband Inc.'s AVERSA(R) technology receives Notice of Allowance from United States Patent and Trademark Office (USPTO)Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of pharmaceutical products, contract research and development services and the manufacture of transdermal products focused on preventing opioid abuse, today announced thatRHEA-AIvery negative
10/01/21 12:00 PMNasdaq, OTC : NTRB, NTRBWofferingNutriband Inc. Prices $6.6 million Public Offering and Announces Uplisting to the NASDAQ Capital MarketNutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW), a company engaged in the development of pharmaceutical products, contract research and development services and the manufacture of transdermal products focused on preventing opioid abuse, announced that itsRHEA-AIneutral
10/01/21 9:45 AMOTC, Nasdaq : NTRB, NTRBWofferingNutriband Inc. Prices $6.6 million Public Offering and Announces Uplisting to the NASDAQ Capital MarketNutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a company engaged in the development of pharmaceutical products focused on preventing opioid abuse, contract research and development services and the contract manufacturing of topical and transdermalRHEA-AIneutral
09/15/20 8:31 AMOTC : NTRBNutriband Inc. Signs Exclusive Distribution Agreement With Oran Textiles for Cifra Reusable V-Block Coated FacemasksNutriband Inc. (OTCQB: NTRB), announced that it has agreed terms with Irish based Oran Textiles Ltd. for the US and Korean distribution rights for Oran Textiles V-block coated facemasks. The masks, are a marriage of Italian based Cifra's WarpmaskRHEA-AIneutral
09/02/20 8:59 AMOTC : NTRBacquisitionNutriband Inc. Completes Acquisition of Transdermal Manufacturing Business for $7.5 MillionNutriband Inc. (OTCQB: NTRB), a Nevada Corporation, announced that it has completed the acquisition of Pocono Coated Product's Transdermal and Health product manufacturing business effective August 31, 2020.Pocono Coated Products was established inRHEA-AIneutral
